RETRACTION: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo (Retraction of Vol 13, art no 527, 2013)Yu-Yin Xu,Li Chen,Gui-Lan Wang,Jia-Ming Zhou,Yi-Xin Zhang,Yin-Ze Wei,Yuan-Yuan Zhu,Jing QinBMC CANCER(2023)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要